Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome is an extremely rare ectodermal dysplasia syndrome characterized by hypotrichosis universalis with mild to severe scarring alopecia, acro-osteolysis, onychogryphosis, thin and tapered fingertips, periodontitis and caries leading to premature teeth loss, linear or reticular palmoplantar keratoderma and erythematous, scaling, psoriasis-like skin lesions on arms and legs. Lingua plicata and ventricular tachycardia have also been observed.
Biomarker and diagnostic research for hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome.
248 publications have been identified in PubMed for hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome. Kisho has analyzed 50 by research type. Research spans Review / Meta-Analysis (38%), Case Report / Case Series (28%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 19 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:36 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies | 14 | 28% |
Laboratory research | 6 | 12% |
Other research | 5 | 10% |
Disease patterns and progression | 2 | 4% |
New treatment approaches | 2 | 4% |
Testing and diagnosis research | 1 | 2% |
Clinical study results | 1 | 2% |
Cadiravane S (2026). [PMID: 41818120](https://pubmed.ncbi.nlm.nih.gov/41818120/). *J Assoc Physicians India*. [Case Report / Case Series]
Protonotarios I (2026). [PMID: 41936932](https://pubmed.ncbi.nlm.nih.gov/41936932/). *Hellenic J Cardiol*. [Review / Meta-Analysis]
Saleh D (2026). [PMID: 30335335](https://pubmed.ncbi.nlm.nih.gov/30335335/). *Unknown Journal*. [Other]
Rossel VSVJ (2026). [PMID: 41781296](https://pubmed.ncbi.nlm.nih.gov/41781296/). *J Dermatol Sci*. [Gene Therapy / Novel Therapeutics]
Rautiainen N (2026). [PMID: 41074678](https://pubmed.ncbi.nlm.nih.gov/41074678/). *Am J Med Genet A*. [Case Report / Case Series]
Piątkiewicz M (2026). [PMID: 41884385](https://pubmed.ncbi.nlm.nih.gov/41884385/). *Clin Cosmet Investig Dermatol*. [Review / Meta-Analysis]
Alibrahim L (2026). [PMID: 41755622](https://pubmed.ncbi.nlm.nih.gov/41755622/). *Dermatol Reports*. [Epidemiology / Natural History]
Tsatsopoulou A (2026). [PMID: 40316016](https://pubmed.ncbi.nlm.nih.gov/40316016/). *Hellenic J Cardiol*. [Review / Meta-Analysis]
Vashisht P (2026). [PMID: 28613704](https://pubmed.ncbi.nlm.nih.gov/28613704/). *Unknown Journal*. [Other]
Sidorina A (2026). [PMID: 41429203](https://pubmed.ncbi.nlm.nih.gov/41429203/). *J Lipid Res*. [Diagnostic / Biomarker]